Therefore, in current work, we first studied the impact of CSNK2A1 expression on OS and TTFT of CLL patients and conducted bioinformatic investigations54,55 to identify possible roles of CSNK2A1 in CLL progression. Here, CSNK2A1 is linked to B-cell chronic lymphocytic leukemia.